Concepedia

Karin Schlegelmilch

KS

Statistics

Publications

8

Citations

2.8K

H-Index

8

Active since

2011

Affiliations

Harvard University(Current)

Boston Children's Hospital

Harvard Stem Cell Institute

The Francis Crick Institute

Freie Universität Berlin

Karin Schlegelmilch is an author at Harvard University specializing in hippo signaling pathway, hippo signaling, and gene expression.

ORCID

Publications per year

2011–2023

8

Publications

8

Yap1 Acts Downstream of α-Catenin to Control Epidermal Proliferation

Karin Schlegelmilch, Morvarid Mohseni, Oktay Kirak et al. · Cell · 2011 · 1.1K citations · Full text

, , +13

YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy

Alexander von Gise, Zhiqiang Lin, Karin Schlegelmilch et al. · Proceedings of the National Academy of Sciences · 2012 · 580 citations · Full text

, , +17

YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29

Karen Tumaneng, Karin Schlegelmilch, Ryan C. Russell et al. · Nature Cell Biology · 2012 · 456 citations · Full text

, , +10

Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer

Masaki Mori, Robinson Triboulet, Morvarid Mohseni et al. · Cell · 2014 · 342 citations · Full text

, , +14

A FIJI macro for quantifying pattern in extracellular matrix

Esther Wershof, Danielle Park, David J. Barry et al. · Life Science Alliance · 2021 · 174 citations · Full text

, , +17

1–5 of 8